Cargando…
晚期肺腺癌患者一线治疗前后EGFR基因突变差异性分析
BACKGROUND AND OBJECTIVE: Epidermal growth factor receptor (EGFR)-based targeted therapy improves the survival of patients with advanced lung adenocarcinoma harboring EGFR mutations. However, factors including treatment or heterogeneity partly contribute to EGFR genetic status alteration between bas...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246999/ https://www.ncbi.nlm.nih.gov/pubmed/30454543 http://dx.doi.org/10.3779/j.issn.1009-3419.2018.11.03 |